Literature DB >> 27278883

The Route to HPV-Associated Neoplastic Transformation: A Review of the Literature.

Pinar Tulay1, Nedime Serakinci1.   

Abstract

Human papillomaviruses (HPVs)-small, nonenveloped viruses with double-stranded circular DNA-are believed to have a role in the progression of cancer. However, the exact mechanisms are not well established. The interference of HPV proteins, especially E6 and E7, in the cell cycle is considered to be the main pathway. It is still questioned whether the expression of these proteins or the viral load is more important in neoplastic transformation. Furthermore, HPV is believed to adapt mechanisms to evade the host cell immune system; persistent HPV infection may also play a role in oncogenic transformation by causing genomic instability and local immune suppression. These factors may cause accumulation of genomic alterations within the host cell and integration of the viral genome into the host genome. In recent years, epigenetic modifications, such as methylation, have also been considered to take part in neoplastic transformation. All of these alterations to the genome may be favorable to the development of cancer. This article highlights the association of HPV in neoplastic transformation and cancer progression.

Entities:  

Mesh:

Year:  2016        PMID: 27278883     DOI: 10.1615/CritRevEukaryotGeneExpr.v26.i1.40

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  6 in total

1.  Epidemiological investigation on the cervical health of lesbians in Beijing, China.

Authors:  Xiangfan Chen; Hong Yan; Yingnan Cao; Shiyue Li; Ningxi Yang; Xiaoyan Li
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

2.  Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer.

Authors:  Ishita Gupta; Monika Ulamec; Melita Peric-Balja; Snjezana Ramic; Ala-Eddin Al Moustafa; Semir Vranic; Halema F Al-Farsi
Journal:  Hum Vaccin Immunother       Date:  2021-10-08       Impact factor: 4.526

3.  Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer.

Authors:  Yanyun Ma; Chunxia Wang; Mengqi Shi; Mingshan Li; Lin Li; Tuanjie Che; Jing Qu
Journal:  Mol Clin Oncol       Date:  2022-09-02

4.  The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually.

Authors:  Lindsey Asti; Colin Hopley; Cameron Avelis; Sarah M Bartsch; Leslie E Mueller; Molly Domino; Sarah N Cox; Jeffrey C Andrews; Samuel L Randall; Owen J Stokes-Cawley; Caitlin Asjes; Bruce Y Lee
Journal:  Sex Transm Dis       Date:  2021-05-01       Impact factor: 2.830

5.  High-risk human papillomaviruses and Epstein-Barr virus in breast cancer in Lebanese women and their association with tumor grade: a molecular and tissue microarray study.

Authors:  Karim Nagi; Ishita Gupta; Nawaf Jurdi; Ayesha Jabeen; Amber Yasmeen; Gerald Batist; Semir Vranic; Ala-Eddin Al-Moustafa
Journal:  Cancer Cell Int       Date:  2021-06-10       Impact factor: 5.722

6.  Evaluation of a Chip-Based, Point-of-Care, Portable, Real-Time Micro PCR Analyzer for the Detection of High-Risk Human Papillomavirus in Uterine Cervix in India.

Authors:  Roopa Hariprasad; Sonam Tulsyan; Roshani Babu; Kavitha Dhanasekaran; Nisha Thakur; Showket Hussain; Richa Tripathi; Vishnubhatla Sreenivas; Shashi Sharma; Latha Sriram; Shalini Singh; Ravi Mehrotra
Journal:  JCO Glob Oncol       Date:  2020-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.